If you experience unexplained weight gain while taking BPC-157, it is important to speak with your healthcare provider to rule out any other potential causes
However, some scholars have proposed that the effect of GLP-1 in the liver is indirectly mediated by multiple mechanisms, such as reducing fat absorption or inhibiting fat cells through acyl-CoA synthetase long chain family member 1 (ACSL1), CCAAT/enhancer binding protein (C/EBP), peroxisome proliferator-activated receptor- (PPAR), and sterol regulatory element binding protein-1c (SREBP-1c) pathways to achieve the purpose of reducing liver lipids [38]
Pajecki D, Halpern A, Cercato C, et al
[5] Metformin with GLP-1 RA: Rationale for Consideration in Obese T2D Patients The rationale for combining metformin with a GLP-1 receptor agonist lies in their complementary mechanisms across metabolic tissues
Sixty percent of the patients had a history of diabetes
Every time they eat carbohydrates, their pancreas may still release two, three, or even six times the amount of insulin needed
